AA Stock Cash Flow Statements
The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Quarterly Cash Flow Statements
Quarterly
|
Annual
Unit: USD | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-06-30 | 2018-03-31 | 2017-12-31 | 2017-09-30 | 2017-06-30 | 2017-03-31 | 2016-12-31 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash from operations | -223,000,000 | ||||||||||||||||||
net income | -307,000,000 | -227,000,000 | -193,000,000 | -121,000,000 | -232,000,000 | -769,000,000 | -150,000,000 | 139,000,000 | 230,000,000 | 274,000,000 | -56,000,000 | 169,000,000 | 138,000,000 | 308,000,000 | -143,000,000 | ||||
adjustments to reconcile net income to cash from operations: | |||||||||||||||||||
depreciation, depletion, and amortization | 161,000,000 | 163,000,000 | 163,000,000 | 153,000,000 | 153,000,000 | 149,000,000 | 152,000,000 | 170,000,000 | 183,000,000 | 184,000,000 | 174,000,000 | 172,000,000 | 193,000,000 | 194,000,000 | 188,000,000 | 195,000,000 | 190,000,000 | 179,000,000 | 182,000,000 |
deferred income taxes | -63,000,000 | 134,000,000 | -120,000,000 | -12,000,000 | -24,000,000 | 0 | -29,000,000 | 23,000,000 | -44,000,000 | -5,000,000 | 31,000,000 | 33,000,000 | -20,000,000 | -11,000,000 | 112,000,000 | 14,000,000 | 27,000,000 | 23,000,000 | -52,000,000 |
equity loss, net of dividends | 23,000,000 | ||||||||||||||||||
restructuring and other charges | 202,000,000 | -11,000,000 | 22,000,000 | 24,000,000 | 149,000,000 | 652,000,000 | 37,000,000 | 2,000,000 | 363,000,000 | 185,000,000 | 370,000,000 | 113,000,000 | 231,000,000 | -19,000,000 | 297,000,000 | -10,000,000 | 12,000,000 | 10,000,000 | 209,000,000 |
net income from investing activities – asset sales | 11,000,000 | -1,000,000 | 1,000,000 | 18,000,000 | |||||||||||||||
net periodic pension benefit cost | 3,000,000 | 2,000,000 | 2,000,000 | 1,000,000 | 1,000,000 | 11,000,000 | 34,000,000 | 33,000,000 | 29,000,000 | 30,000,000 | 30,000,000 | 30,000,000 | 41,000,000 | 40,000,000 | 28,000,000 | 28,000,000 | 27,000,000 | 28,000,000 | 23,000,000 |
stock-based compensation | 10,000,000 | 8,000,000 | 6,000,000 | 11,000,000 | 10,000,000 | 8,000,000 | 9,000,000 | 8,000,000 | 1,000,000 | 8,000,000 | 11,000,000 | 10,000,000 | 10,000,000 | 10,000,000 | 3,000,000 | 7,000,000 | 7,000,000 | 7,000,000 | 4,000,000 |
gain on mark-to-market derivative financial contracts | 2,000,000 | -5,000,000 | 27,000,000 | 22,000,000 | -18,000,000 | 39,000,000 | |||||||||||||
other | 20,000,000 | 11,000,000 | 8,000,000 | 11,000,000 | 48,000,000 | 2,000,000 | 1,000,000 | 4,000,000 | 11,000,000 | -5,000,000 | 1,000,000 | 23,000,000 | -18,000,000 | -14,000,000 | 1,000,000 | 34,000,000 | -12,000,000 | 9,000,000 | -28,000,000 |
changes in assets and liabilities, excluding effects of divestitures and foreign currency translation adjustments: | |||||||||||||||||||
increase in receivables | -212,000,000 | -70,000,000 | -108,000,000 | ||||||||||||||||
decrease in inventories | 71,000,000 | 143,000,000 | 41,000,000 | ||||||||||||||||
increase in prepaid expenses and other current assets | -6,000,000 | -30,000,000 | |||||||||||||||||
decrease in accounts payable, trade | -98,000,000 | -273,000,000 | |||||||||||||||||
decrease in accrued expenses | -22,000,000 | -14,000,000 | -71,000,000 | -3,000,000 | -45,000,000 | -19,000,000 | |||||||||||||
increase in taxes, including income taxes | 18,000,000 | -24,000,000 | 14,000,000 | -2,000,000 | -299,000,000 | -43,000,000 | 17,000,000 | 84,000,000 | 96,000,000 | ||||||||||
pension contributions | -6,000,000 | -4,000,000 | -11,000,000 | -5,000,000 | -4,000,000 | -3,000,000 | -11,000,000 | -48,000,000 | -106,000,000 | -12,000,000 | -48,000,000 | -7,000,000 | -652,000,000 | -40,000,000 | -24,000,000 | -35,000,000 | -26,000,000 | -21,000,000 | -21,000,000 |
decrease (increase) in noncurrent assets | 9,000,000 | -13,000,000 | 32,000,000 | ||||||||||||||||
decrease in noncurrent liabilities | -39,000,000 | -34,000,000 | 45,000,000 | -46,000,000 | -58,000,000 | -37,000,000 | |||||||||||||
financing activities | |||||||||||||||||||
additions to debt | 965,000,000 | 47,000,000 | 55,000,000 | 0 | 25,000,000 | 492,000,000 | 61,000,000 | 18,000,000 | 0 | 1,000,000 | 2,000,000 | ||||||||
payments on debt | -221,000,000 | -33,000,000 | -23,000,000 | -15,000,000 | -1,000,000 | -3,000,000 | -4,000,000 | -5,000,000 | -45,000,000 | -5,000,000 | -5,000,000 | -18,000,000 | |||||||
proceeds from the exercise of employee stock options | 0 | 0 | 0 | 1,000,000 | 0 | 0 | 1,000,000 | 0 | 1,000,000 | 7,000,000 | 15,000,000 | 5,000,000 | 20,000,000 | ||||||
dividends paid on alcoa common stock | -19,000,000 | -18,000,000 | -18,000,000 | -18,000,000 | -18,000,000 | -18,000,000 | |||||||||||||
payments related to tax withholding on stock-based compensation awards | -15,000,000 | 0 | 0 | 0 | -34,000,000 | 0 | |||||||||||||
financial contributions for the divestiture of businesses | -7,000,000 | -8,000,000 | -19,000,000 | -11,000,000 | -14,000,000 | -10,000,000 | -12,000,000 | -12,000,000 | |||||||||||
contributions from noncontrolling interest | 61,000,000 | 24,000,000 | 42,000,000 | 36,000,000 | 86,000,000 | 67,000,000 | 10,000,000 | 20,000,000 | 1,000,000 | 20,000,000 | 56,000,000 | 53,000,000 | 24,000,000 | 0 | 32,000,000 | 24,000,000 | |||
distributions to noncontrolling interest | -6,000,000 | -6,000,000 | -2,000,000 | -16,000,000 | -6,000,000 | -74,000,000 | -75,000,000 | -31,000,000 | -84,000,000 | -102,000,000 | -72,000,000 | -214,000,000 | -118,000,000 | -267,000,000 | -98,000,000 | -89,000,000 | -98,000,000 | -57,000,000 | |
cash provided from financing activities | 754,000,000 | ||||||||||||||||||
investing activities | |||||||||||||||||||
capital expenditures | -101,000,000 | -188,000,000 | -145,000,000 | -115,000,000 | -83,000,000 | -128,000,000 | -77,000,000 | -91,000,000 | -134,000,000 | -87,000,000 | -89,000,000 | -69,000,000 | -95,000,000 | -74,000,000 | -150,000,000 | -96,000,000 | -88,000,000 | -71,000,000 | -146,000,000 |
proceeds from the sale of assets | 1,000,000 | 0 | 1,000,000 | 1,000,000 | 1,000,000 | 0 | 199,000,000 | 12,000,000 | 0 | 11,000,000 | |||||||||
additions to investments | -17,000,000 | -19,000,000 | -15,000,000 | -16,000,000 | -20,000,000 | -11,000,000 | -2,000,000 | -1,000,000 | 0 | -1,000,000 | -110,000,000 | -1,000,000 | -22,000,000 | -8,000,000 | -11,000,000 | -25,000,000 | 0 | ||
cash from investing activities | -117,000,000 | -166,000,000 | -120,000,000 | -102,000,000 | -134,000,000 | -76,000,000 | -199,000,000 | -59,000,000 | |||||||||||
effect of exchange rate changes on cash and cash equivalents and restricted cash | -6,000,000 | 3,000,000 | 2,000,000 | -18,000,000 | -2,000,000 | -24,000,000 | 4,000,000 | -10,000,000 | 5,000,000 | -6,000,000 | -11,000,000 | 4,000,000 | |||||||
net change in cash and cash equivalents and restricted cash | 408,000,000 | 17,000,000 | -67,000,000 | -154,000,000 | -223,000,000 | -207,000,000 | 136,000,000 | -51,000,000 | 39,000,000 | 7,000,000 | -183,000,000 | -96,000,000 | -108,000,000 | -162,000,000 | |||||
cash and cash equivalents and restricted cash at beginning of year | 1,047,000,000 | 0 | 0 | 0 | 1,474,000,000 | 0 | 0 | 883,000,000 | 0 | 0 | 0 | 1,116,000,000 | 0 | 1,365,000,000 | |||||
cash and cash equivalents and restricted cash at end of period | 1,455,000,000 | -67,000,000 | -154,000,000 | 1,251,000,000 | 136,000,000 | 832,000,000 | 7,000,000 | -183,000,000 | 1,020,000,000 | -108,000,000 | 1,203,000,000 | ||||||||
alcoa corporation shareholders | |||||||||||||||||||
common stock | |||||||||||||||||||
balance at january 1, 2023 | 2,000,000 | 0 | 0 | 2,000,000 | |||||||||||||||
other comprehensive | |||||||||||||||||||
net effect of tax withholding for compensation plans and exercise of stock options | |||||||||||||||||||
contributions | |||||||||||||||||||
distributions | |||||||||||||||||||
balance at march 31, 2023 | 2,000,000 | 0 | 0 | 2,000,000 | |||||||||||||||
balance at january 1, 2024 | 2,000,000 | ||||||||||||||||||
other comprehensive income | |||||||||||||||||||
balance at march 31, 2024 | 2,000,000 | ||||||||||||||||||
equity loss | |||||||||||||||||||
net gain from investing activities—asset sales | |||||||||||||||||||
premium paid on early redemption of debt | |||||||||||||||||||
decrease (increase) in receivables | 31,000,000 | 40,000,000 | 156,000,000 | 33,000,000 | 7,000,000 | ||||||||||||||
decrease | 26,000,000 | 58,000,000 | 36,000,000 | 17,000,000 | |||||||||||||||
decrease (increase) in prepaid expenses and other current assets | -14,000,000 | 4,000,000 | -19,000,000 | 10,000,000 | |||||||||||||||
increase in accounts payable, trade | -108,000,000 | 268,000,000 | 90,000,000 | ||||||||||||||||
increase in noncurrent assets | -31,000,000 | -113,000,000 | -37,000,000 | -29,000,000 | -23,000,000 | -3,000,000 | |||||||||||||
cash provided from operations | 168,000,000 | 55,000,000 | |||||||||||||||||
repurchase of common stock | -150,000,000 | ||||||||||||||||||
cash provided from (used for) financing activities | 6,000,000 | 35,000,000 | -24,000,000 | 40,000,000 | |||||||||||||||
sale of investments | 0 | ||||||||||||||||||
cash (used for) provided from investing activities | -138,000,000 | -100,000,000 | -74,000,000 | ||||||||||||||||
cash and cash equivalents and restricted cash at end of year | |||||||||||||||||||
balance at december 31, 2020 | |||||||||||||||||||
balance at december 31, 2021 | |||||||||||||||||||
balance at december 31, 2022 | |||||||||||||||||||
balance at december 31, 2023 | |||||||||||||||||||
equity loss (income), net of dividends | 38,000,000 | ||||||||||||||||||
decrease in receivables | 42,000,000 | 43,000,000 | |||||||||||||||||
decrease (increase) in inventories | 144,000,000 | 5,000,000 | 17,000,000 | ||||||||||||||||
decrease in taxes, including income taxes | 94,000,000 | -133,000,000 | -13,000,000 | ||||||||||||||||
cash (used for) provided from operations | 69,000,000 | -13,000,000 | -163,000,000 | -90,000,000 | 239,000,000 | ||||||||||||||
balance at january 1, 2022 | 0 | 0 | 2,000,000 | 0 | |||||||||||||||
balance at march 31, 2022 | 0 | 0 | 2,000,000 | 0 | |||||||||||||||
balance at june 30, 2022 | 0 | 0 | |||||||||||||||||
balance at september 30, 2022 | |||||||||||||||||||
balance at june 30, 2023 | 0 | ||||||||||||||||||
other comprehensive loss | |||||||||||||||||||
balance at september 30, 2023 | |||||||||||||||||||
decrease in prepaid expenses and other current assets | 2,000,000 | 11,000,000 | 13,000,000 | 2,000,000 | 13,000,000 | ||||||||||||||
equity loss (earnings), net of dividends | 93,000,000 | ||||||||||||||||||
equity earnings, net of dividends | 26,000,000 | 9,000,000 | -2,000,000 | 17,000,000 | -3,000,000 | -5,000,000 | -6,000,000 | ||||||||||||
net gain from investing activities – asset sales | 2,000,000 | 1,000,000 | -177,000,000 | -5,000,000 | 7,000,000 | -8,000,000 | 2,000,000 | -5,000,000 | 1,000,000 | ||||||||||
increase in inventories | 77,000,000 | -136,000,000 | -16,000,000 | 16,000,000 | -102,000,000 | ||||||||||||||
cash from financing activities | -185,000,000 | -71,000,000 | -44,000,000 | -199,000,000 | -147,000,000 | ||||||||||||||
cash and cash equivalents and restricted cash (q) at end of period | -207,000,000 | ||||||||||||||||||
balance at january 1, 2021 | 0 | ||||||||||||||||||
common stock issued: compensation plans | |||||||||||||||||||
balance at march 31, 2021 | 0 | ||||||||||||||||||
balance at june 30, 2021 | 0 | ||||||||||||||||||
balance at september 30, 2021 | |||||||||||||||||||
benefit from bad debt expense | 0 | 2,000,000 | 0 | 1,000,000 | 0 | 20,000,000 | |||||||||||||
cash provided from (used for) operations | 174,000,000 | 455,000,000 | 384,000,000 | 311,000,000 | 74,000,000 | ||||||||||||||
(decrease) in accounts payable, trade | -62,000,000 | -121,000,000 | -55,000,000 | 15,000,000 | -159,000,000 | -106,000,000 | -45,000,000 | ||||||||||||
(decrease) in accrued expenses | -35,000,000 | -85,000,000 | -28,000,000 | -96,000,000 | -33,000,000 | -18,000,000 | -57,000,000 | -186,000,000 | -243,000,000 | -82,000,000 | -57,000,000 | -181,000,000 | 18,000,000 | ||||||
(decrease) in noncurrent liabilities | -3,000,000 | -6,000,000 | -7,000,000 | -23,000,000 | 19,000,000 | -20,000,000 | |||||||||||||
cash provided from (used for) investing activities | -79,000,000 | 107,000,000 | -87,000,000 | 131,000,000 | |||||||||||||||
second quarter ended june 30, 2019 | |||||||||||||||||||
balance at march 31, 2019 | 0 | 2,000,000 | |||||||||||||||||
balance at june 30, 2019 | 0 | ||||||||||||||||||
second quarter ended june 30, 2020 | |||||||||||||||||||
balance at march 31, 2020 | 0 | 2,000,000 | |||||||||||||||||
balance at june 30, 2020 | |||||||||||||||||||
six months ended june 30, 2019 | |||||||||||||||||||
balance at december 31, 2018 | 0 | 2,000,000 | 0 | ||||||||||||||||
six months ended june 30, 2020 | |||||||||||||||||||
balance at december 31, 2019 | 0 | 2,000,000 | |||||||||||||||||
(decrease) in taxes, including income taxes | -11,000,000 | -27,000,000 | -17,000,000 | ||||||||||||||||
increase in noncurrent liabilities | -43,000,000 | 1,000,000 | -50,000,000 | 55,000,000 | |||||||||||||||
first quarter ended march 31, 2019 | |||||||||||||||||||
first quarter ended march 31, 2020 | |||||||||||||||||||
net | -355,000,000 | -147,000,000 | -293,000,000 | -58,000,000 | -120,000,000 | ||||||||||||||
(increase) in noncurrent assets | 0 | 8,000,000 | -22,000,000 | -10,000,000 | -36,000,000 | -13,000,000 | -42,000,000 | ||||||||||||
cash (used for) provided from financing activities | -81,000,000 | -115,000,000 | -78,000,000 | -260,000,000 | |||||||||||||||
third quarter ended september 30, 2018 | |||||||||||||||||||
balance at june 30, 2018 | 0 | ||||||||||||||||||
balance at september 30, 2018 | |||||||||||||||||||
third quarter ended september 30, 2019 | |||||||||||||||||||
balance at september 30, 2019 | |||||||||||||||||||
nine months ended september 30, 2018 | |||||||||||||||||||
balance at december 31, 2017 | 0 | 0 | 2,000,000 | ||||||||||||||||
nine months ended september 30, 2019 | |||||||||||||||||||
changes in assets and liabilities, excluding effects of foreign currency translation adjustments: | |||||||||||||||||||
second quarter ended june 30, 2018 | |||||||||||||||||||
six months ended june 30, 2018 | |||||||||||||||||||
changes in assets and liabilities, excluding effects of acquisitions, divestitures, and foreign currency translation adjustments: | |||||||||||||||||||
net transfers from former parent company | |||||||||||||||||||
establishment of additional defined benefit plans | |||||||||||||||||||
cash provided at separation to parent company | |||||||||||||||||||
separation-related adjustments | |||||||||||||||||||
issuance of common stock | |||||||||||||||||||
balance at june 30, 2017 | |||||||||||||||||||
net transfers from (to) former parent company | |||||||||||||||||||
cash and cash equivalents at end of year | |||||||||||||||||||
establishment of defined benefit plans | |||||||||||||||||||
balance at september 30, 2016 | |||||||||||||||||||
balance at september 30, 2017 | |||||||||||||||||||
balance at december 31, 2013 | |||||||||||||||||||
distributions to noncontrolling interests | |||||||||||||||||||
balance at june 30, 2015 | |||||||||||||||||||
balance at september 30, 2015 |